Fundz

Who to call at Evommune, and when

Fundz watches for the moments Evommune starts buying, and tells you who to reach.

  • An alert the day Evommune raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evommune, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evommune. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Evommune Enters Exclusive License Agreement with Hinova Pharmaceuticals

Nov 04, 2026

Contract Type

licensing

Palo AltoBiotechnologyHealth Care

Description

On November 4, 2026, Evommune, Inc. entered into an Exclusive License Agreement with Hinova Pharmaceuticals Inc. for the rights to develop and commercialize VAV1 degraders globally, with specific exclusions for Greater China. The agreement includes a one-time upfront payment of $20 million and warrants for shares valued at $10 million

Company Information

Company

Evommune

Location

Palo Alto, California, United States

About

Evommune, Inc. is a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases. The company is creating game-changing science with the goal of delivering therapies that address symptoms and halt progressive disease.

Related People

Luis
Likely contact at this company
••••••••@••••••••

See Luis's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Evommune's next move

Learn about Strategic plan

Evommune signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.